Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Why Type One Diabetes Patients Need Closed Loop Insulin Systems

For a while now there has been a heated debate surrounding hybrid and closed loop insulin systems.

Read More »

Tivity Health to buy Nutrisystem for $1.4 billion

Tivity Health Inc. said the company would acquire Nutrisystem Inc. in a cash-and-stock deal that values the weight management product developer at $1.4 billion.

Read More »

Gilead Sciences snares Roche veteran O’Day as CEO

Drugmaker Gilead Sciences Inc. named Roche Holding AG’s Daniel O’Day as the company’s new chief executive, tapping an industry veteran to fill a management vacuum.

Read More »

Moderna Therapeutics Sets Record for Biggest Biotech IPO

The long-awaited and massively hyped initial public offering (IPO) of Moderna Therapeutics hit the market.

Read More »

CMO perspective on world without Medicare rebates

For chief medical officers of health systems, a world without Medicare rebates complicates the selection of a preferred treatment while also opening opportunities for improved clinical and financial outcomes.

Read More »

J&J unit to resolve charity kickback probe

A unit of Johnson & Johnson will pay $360 million to resolve an investigation into the company’s financial support of a charity that helped Medicare patients cover out-of-pocket drug costs.

Read More »

Impel NeuroPharma Closes $67.5 Million Series D to Advance CNS Portfolio

Seattle-based Impel NeuroPharma closed on a Series D financing totaling $67.5 million, co-led by KKR and Northwest Venture Partners.

Read More »

Medtronic Will Pay $51 Million To Settle DOJ Investigation Against Two Company Acquisitions

Medtronic will pay a total of nearly $51 million to resolve three legal claims against Covidien Plc and ev3 Inc., two companies that are now part of the Ireland-based medtech company. Medtronic itself had no role in the wrongdoings that resulted in the multi-million fines.

Read More »

Despite Opposition, Takeda Shareholders Approve Shire Acquisition

Shareholders of Japan’s Takeda Pharmaceutical voted to approve the acquisition of Ireland’s Shire for about $58 billion.

Read More »

Mylan to recall all batches of blood pressure medicine valsartan in U.S.

Mylan NV is issuing a nationwide voluntary recall of all lots of the company’s blood pressure medicine valsartan.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom